SAGENT PHARMS INC FDA Approval ANDA 202462

ANDA 202462

SAGENT PHARMS INC

FDA Drug Application

Application #202462

Application Sponsors

ANDA 202462SAGENT PHARMS INC

Marketing Status

Prescription001

Application Products

001INJECTABLE;INJECTIONEQ 500MG BASE/VIAL0CHLOROTHIAZIDE SODIUMCHLOROTHIAZIDE SODIUM

FDA Submissions

UNKNOWN; ORIG1AP2015-05-29

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAP

CDER Filings

SAGENT PHARMS INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 202462
            [companyName] => SAGENT PHARMS INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"CHLOROTHIAZIDE SODIUM","activeIngredients":"CHLOROTHIAZIDE SODIUM","strength":"EQ 500MG BASE\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"05\/29\/2015","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2015-05-29
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.